Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis

References

• Simpson E. P., Yen A. A., Appel S. H. Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 2003; 15: 730–6
   PubMed Web of Science ®Google Scholar
• Bowling A. C., Schulz J. B., Brown R. H., Jr., Beal M. F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322–5
   PubMed Web of Science ®Google Scholar
• Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917: 97–104
   PubMed Web of Science ®Google Scholar
• Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064–74
   PubMed Web of Science ®Google Scholar
• Oteiza P. I., Uchitel O. D., Carrasquedo F., Dubrovski A. L., Roma J. C., Fraga C. G. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 1997; 22: 535–9
   PubMed Web of Science ®Google Scholar
• Bogdanov M., Brown R. H., Matson W., Smart R., Hayden D., O'Donnell H., et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med 2000; 29: 652–8
   PubMed Web of Science ®Google Scholar
• Cashman J. R. Human flavin‐containing mono‐oxygenase: substrate specificity and role in drug metabolism. Curr Drug Metab 2000; 1: 181–91
   PubMed Web of Science ®Google Scholar
• Phillips I. R., Dolphin C. T., Clair P., Hadley M. R., Hutt A. J., McCombie R. R., et al. The molecular biology of the flavin‐containing monooxygenases of man. Chem Biol Interact 1995; 96: 17–32
   PubMed Web of Science ®Google Scholar
• Hernandez D., Janmohamed A., Chandan P., Phillips I. R., Shephard E. A. Organization and evolution of the flavin‐containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 2004; 14: 117–30
   PubMedGoogle Scholar
• Janmohamed A., Hernandez D., Phillips I. R., Shephard E. A. Cell‐, tissue‐, sex‐ and developmental stage‐specific expression of mouse flavin‐containing monooxygenases (Fmos). Biochem Pharmacol 2004; 68: 73–83
   PubMed Web of Science ®Google Scholar
• Bhamre S., Bhagwat S. V., Shankar S. K., Boyd M. R., Ravindranath V. Flavin‐containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes. Brain Res 1995; 672: 276–80
   PubMed Web of Science ®Google Scholar
• Bhagwat S. V., Bhamre S., Boyd M. R., Ravindranath V. Cerebral metabolism of imipramine and a purified flavin‐containing monooxygenase from human brain. Neuropsychopharmacology 1996; 15: 133–42
   PubMed Web of Science ®Google Scholar
• Bhamre S., Ravindranath V. Presence of flavin‐containing monooxygenase in rat brain. Biochem Pharmacol 1991; 42: 442–4
   PubMed Web of Science ®Google Scholar
• Suh J. K., Poulsen L. L., Ziegler D. M., Robertus J. D. Redox regulation of yeast flavin‐containing monooxygenase. Arch Biochem Biophys 2000; 381: 317–22
   PubMed Web of Science ®Google Scholar
• Suh J. K., Poulsen L. L., Ziegler D. M., Robertus J. D. Yeast flavin‐containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum. Proc Natl Acad Sci. USA 1999; 96: 2687–91
   PubMed Web of Science ®Google Scholar
• Suh J. K., Robertus J. D. Yeast flavin‐containing monooxygenase is induced by the unfolded protein response. Proc Natl Acad Sci. USA 2000; 97: 121–6
   PubMed Web of Science ®Google Scholar
• Bains J. S., Shaw C. A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress‐mediated neuronal death. Brain Res Brain Res Rev 1997; 25: 335–58
   PubMed Web of Science ®Google Scholar
• Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett 1999; 260: 204–6
   PubMed Web of Science ®Google Scholar
• Malaspina A., Kaushik N., de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001; 77: 132–45
   PubMed Web of Science ®Google Scholar
• Malaspina A., de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Res Rev 2004; 45: 213–29
   PubMed Web of Science ®Google Scholar
• Dolphin C. T., Riley J. H., Smith R. L., Shephard E. A., Phillips I. R. Structural organization of the human flavin‐containing monooxygenase 3 gene (FMO3), the favoured candidate for fish‐odour syndrome, determined directly from genomic DNA. Genomics 1997; 46: 260–7
   PubMed Web of Science ®Google Scholar
• Dolphin C. T., Beckett D. J., Janmohamed A., Cullingford T. E., Smith R. L., Shephard E. A., et al. The flavin‐containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, non‐functional protein. J Biol Chem 1998; 273: 30599–607
   PubMed Web of Science ®Google Scholar
• Krueger S. K., Williams D. E., Yueh M. F., Martin S. R., Hines R. N., Raucy J. L., et al. Genetic polymorphisms of flavin‐containing monooxygenase (FMO). Drug Metab Rev 2002; 34: 523–32
   PubMed Web of Science ®Google Scholar
• Krueger S. K., Williams D. E. Mammalian flavin‐containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005; 106: 357–87
   PubMed Web of Science ®Google Scholar
• Hines R. N., Luo Z., Hopp K. A., Cabacungan E. T., Koukouritaki S. B., McCarver D. G. Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6). J Pharmacol Exp Ther 2003; 306: 1210–8, Epub 2003, June 26
   PubMed Web of Science ®Google Scholar
• Lahiri D. K., Bye S., Nurnberger J. I., Jr., Hodes M. E., Crisp M. A non‐organic and non‐enzymatic extraction method gives higher yields of genomic DNA from whole‐blood samples than do nine other methods tested. J Biochem Biophys Methods 1992; 25: 193–205
   PubMedGoogle Scholar
• Brooks B. R., Miller R. G., Swash M., Munsat T. L., World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revisited criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Terwilliger J. D., Ott J., editors. Handbook of Human Genetic Linkage. Johns Hopkins University Press, Baltimore 1994
   Google Scholar
• Gingerich T. J., Feige J. J., LaMarre J. AU‐rich elements and the control of gene expression through regulated mRNA stability. Anim Health Res Rev 2004; 5: 49–63
   PubMedGoogle Scholar
• Conne B., Stutz A., Vassalli J. D. The 3' untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat Med 2000; 6: 637–41
   PubMed Web of Science ®Google Scholar
• van Landeghem G. F., Tabatabaie P., Beckman G., Beckman L., Andersen P. M. Manganese‐containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol 1999; 6: 639–44
   PubMed Web of Science ®Google Scholar
• Falls J. G., Ryu D. Y., Cao Y., Levi P. E., Hodgson E. Regulation of mouse liver flavin‐containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 1997; 342: 212–23
   PubMed Web of Science ®Google Scholar
• Zhang A. Q., Mitchell S. C., Smith R. L. Exacerbation of symptoms of fish‐odour syndrome during menstruation. Lancet 1996; 348: 1740–1
   PubMed Web of Science ®Google Scholar
• Zhang J., Cashman J. R. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos 2006; 34: 19–26
   PubMed Web of Science ®Google Scholar
• Mayeux R. Mapping the new frontier: complex genetic disorders. J Clin Invest 2005; 115: 1404–7
   PubMed Web of Science ®Google Scholar